Key Takeaways
- • The hedge fund industry returned 5.46% in April 2020, significantly underperforming the S&P 500 Total Return Index's 12.8% gain during the best month for US stocks in decades, according to the Barclay Hedge Fund Index compiled by BarclayHedge.
- • Year-to-date through April, hedge funds remain down 7.01% compared to the S&P 500's 9.29% decline, positioning the industry ahead of broad equities on a cumulative basis despite April's relative underperformance.
- • Healthcare & Biotechnology hedge funds led all sectors with a 13.27% April return, while Emerging Markets Global Equities (8.84%) and Emerging Markets Asian Equities (8.77%) rebounded strongly after March deterioration, benefiting from government stimulus tailwinds.
- • Only four hedge fund sectors posted positive year-to-date returns through April: Volatility Trading Index (+7.28%), Fixed Income Arbitrage (+2.14%), Option Strategies (approaching 1%), and one additional category, with Volatility Trading being the sole standout performer.
- • Two sectors declined in April—Volatility Trading down 0.17% and Emerging Markets MENA down 2.00%—illustrating uneven sector performance despite broad market recovery driven by massive government stimulus programs offsetting coronavirus-related economic deterioration.
Summary
The hedge fund industry capitalized on April's equity market rebound to post a 5.46% return, riding gains from massive government stimulus initiatives that buoyed risk assets amid an accelerating global health crisis. However, this performance trailed the S&P 500 Total Return Index's exceptional 12.8% gain, marking April as the best month for US stocks in decades. According to Sol Waksman, president of BarclayHedge, the industry's resilience reflected how "massive government stimulus programs buoyed equity markets and provided a favourable tailwind for hedge funds," even as unemployment surged, oil prices collapsed, and economic activity contracted sharply.
Year-to-date metrics reveal a more favorable hedge fund positioning relative to broad equities. Through April, the hedge fund industry was down 7.01% compared to the S&P 500 Total Return Index's 9.29% decline, indicating that the sector's defensive positioning in the early pandemic period has preserved relative capital despite missing April's outsized rally. This divergence underscores the dual nature of hedge fund performance during market dislocations—protection in sharp drawdowns versus underperformance in strong recoveries.
Sector dispersion was pronounced in April. Healthcare & Biotechnology led substantially with a 13.27% return as investors sought pandemic-related solutions. Emerging market strategies rebounded sharply after March's severe underperformance, with the Emerging Markets Global Equities Index returning 8.84% and the Emerging Markets Asian Equities Index gaining 8.77%. Event Driven strategies posted 8.02%, Equity Long Bias gained 7.73%, and Merger Arbitrage returned 5.41%. Conversely, only two sectors declined: Volatility Trading fell 0.17% and the Emerging Markets MENA Index lost 2.00%.
Year-to-date profitability remains concentrated. Only four hedge fund sectors were in positive territory through April, with the Volatility Trading Index leading at +7.28%—paradoxically the only sector to decline in April—the Fixed Income Arbitrage Index at +2.14%, and the Option Strategies Index approaching 1%, alongside one unspecified additional positive-performing category. This concentration suggests that mean reversion plays and volatility harvesting strategies benefited from elevated market dislocations earlier in the year, while long-biased and equity-sensitive strategies remain underwater.
Year-to-date metrics reveal a more favorable hedge fund positioning relative to broad equities. Through April, the hedge fund industry was down 7.01% compared to the S&P 500 Total Return Index's 9.29% decline, indicating that the sector's defensive positioning in the early pandemic period has preserved relative capital despite missing April's outsized rally. This divergence underscores the dual nature of hedge fund performance during market dislocations—protection in sharp drawdowns versus underperformance in strong recoveries.
Sector dispersion was pronounced in April. Healthcare & Biotechnology led substantially with a 13.27% return as investors sought pandemic-related solutions. Emerging market strategies rebounded sharply after March's severe underperformance, with the Emerging Markets Global Equities Index returning 8.84% and the Emerging Markets Asian Equities Index gaining 8.77%. Event Driven strategies posted 8.02%, Equity Long Bias gained 7.73%, and Merger Arbitrage returned 5.41%. Conversely, only two sectors declined: Volatility Trading fell 0.17% and the Emerging Markets MENA Index lost 2.00%.
Year-to-date profitability remains concentrated. Only four hedge fund sectors were in positive territory through April, with the Volatility Trading Index leading at +7.28%—paradoxically the only sector to decline in April—the Fixed Income Arbitrage Index at +2.14%, and the Option Strategies Index approaching 1%, alongside one unspecified additional positive-performing category. This concentration suggests that mean reversion plays and volatility harvesting strategies benefited from elevated market dislocations earlier in the year, while long-biased and equity-sensitive strategies remain underwater.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.